Veracyte, Inc. (VCYT) Presents at 2026 UBS Global Healthcare Conference TranscriptSeeking Alpha • 11/11/26
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Veracyte (VCYT)GlobeNewsWire • 11/10/26
VCYT Investors Have Opportunity to Join Veracyte, Inc. Fraud Investigation with SBS LawBusiness Wire • 11/09/26
Veracyte Q3 Earnings Call Highlights Slower Growth and Added InvestmentZacks Investment Research • 11/06/26
VCYT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving VeracytePRNewsWire • 11/06/26
Veracyte Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Veracyte (VCYT)PRNewsWire • 11/06/26
VCYT Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud Against Veracyte, Inc.GlobeNewsWire • 11/05/26
Veracyte Crashes Almost 40% On Seismic Shift For Its Best-Selling TestInvestors Business Daily • 11/05/26
Ten Afirma Abstracts to Highlight Thyroid Nodule Diagnosis and Cancer Research at ATA 2026GlobeNewsWire • 11/02/26
Veracyte (VCYT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks Investment Research • 10/28/26
Phase III Trial Shows Veracyte's Decipher Prostate Test Can Predict Benefit from Adding Abiraterone to Treatment in Very High-Risk Prostate CancerGlobeNewsWire • 10/23/26
Will Veracyte (VCYT) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research • 10/21/26
Six Studies to Highlight Veracyte's Genomic Tests Across Breast, Prostate and Bladder Cancer at ESMO 2026GlobeNewsWire • 10/19/26
Veracyte Secures Medicare Reimbursement for Prosigna Breast Risk of Recurrence TestGlobeNewsWire • 10/16/26
Phase III Trial Demonstrates Veracyte's Decipher Prostate Test Predicts Benefit from Adding Hormone Therapy to RadiationGlobeNewsWire • 09/29/26